Virtmed gains $43 million in second round of fundingVirtmed has secured more than $43 million from investors in its second round of funding. Among the investors are eHealth Technology Fund, New Enterprise Associates, Frazier & Co., and the
Virtmed has secured more than $43 million from investors in its second round of funding. Among the investors are eHealth Technology Fund, New Enterprise Associates, Frazier & Co., and the venture arm of 3Com. Virtmed is a three-year-old Cambridge, MA, firm that is banking on the integration of wireless devices, Internet technologies, and existing healthcare information systems to give doctors and nurses access to patient and other data at the point of care.
Virtmeds primary product is a thin-client server designed to sit on-site and direct data between existing databases and handheld devices. The firm has also developed online reporting functions to allow users to update patient charts remotely.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.